Skip to content

Renal Retention of Microbubbles

Study of Whether There is Renal Retention of Lipid Microbubble Ultrasound Contrast Agents

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01647464
Enrollment
10
Registered
2012-07-23
Start date
2012-07-31
Completion date
2012-10-31
Last updated
2016-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

- Study Focus: Renal Retention of Lipid Microbubbles

Brief summary

Flank pain has been reported with ultrasound (US) contrast agents. The purpose of this study is to determine whether there is retention of ultrasound contrast agents in the renal microcirculation, which has been described in mice.

Detailed description

In this study patients undergoing clinically indicated contrast echocardiography will have renal ultrasound performed 10 minutes after completion of contrast infusion to determine the presence and location of renal retention of lipid microbubbles.

Interventions

None listed

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing clinically indicated contrast echo * adequate renal ultrasound images

Exclusion criteria

* chronic inflammatory disease * known kidney disease * immunomodulatory therapy

Design outcomes

Primary

MeasureTime frameDescription
Renal Video Intensity Units10 minVideo intensity units in the kidney 10 min after completion of a clinically indicated contrast echocardiography study.

Countries

United States

Participant flow

Participants by arm

ArmCount
Contrast Administration
Patients undergoing contrast-enhanced echo.
10
Total10

Baseline characteristics

CharacteristicContrast Administration
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Renal Video Intensity Units

Video intensity units in the kidney 10 min after completion of a clinically indicated contrast echocardiography study.

Time frame: 10 min

ArmMeasureValue (MEAN)Dispersion
Contrast AdministrationRenal Video Intensity Units19 units on a scaleStandard Deviation 9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026